“Coming Back from the Dead” Is No Longer Science Fiction

“Coming Back from the Dead” Is No Longer Science Fiction

A man receiving cardiopulmonary resuscitation (CPR).

(Photo credit: spkphotostock/Adobe)


Keep Reading Keep Reading
Sam Parnia
Dr. Sam Parnia MD, PhD is an Associate Professor of Critical Care Medicine at New York University School of Medicine, where he directs the Critical Care and Resuscitation Research Science Center. One of the world's leading experts on cardiac arrest resuscitation, post-cardiac arrest syndrome, and the scientific study of death, Dr. Parnia’s research focus is on developing new methods to save the lives and brains of patients who undergo cardiac arrest, as well as shedding light on what happens to our brains when we die. He also founded and directed the Human Consciousness Project, which featured an international consortium of scientists and physicians researching the nature of consciousness and its relationship to the brain during cardiac arrest. Dr. Parnia is also the author of two popular books, “What Happens When We Die?” and The New York Times bestseller, “Erasing Death: The Science that is Rewriting the Boundaries between Life and Death.”
A new type of cancer therapy is shrinking deadly brain tumors with just one treatment

MRI scans after a new kind of immunotherapy for brain cancer show remarkable progress in one patient just days after the first treatment.

Mass General Hospital

Few cancers are deadlier than glioblastomas—aggressive and lethal tumors that originate in the brain or spinal cord. Five years after diagnosis, less than five percent of glioblastoma patients are still alive—and more often, glioblastoma patients live just 14 months on average after receiving a diagnosis.

But an ongoing clinical trial at Mass General Cancer Center is giving new hope to glioblastoma patients and their families. The trial, called INCIPIENT, is meant to evaluate the effects of a special type of immune cell, called CAR-T cells, on patients with recurrent glioblastoma.

Keep Reading Keep Reading
Sarah Watts

Sarah Watts is a health and science writer based in Chicago.

Artificial Intelligence is getting better than humans at detecting breast cancer

A recent study in The Lancet Oncology showed that AI found 20 percent more cancers on mammogram screens than radiologists alone.

The Lancet Oncology

Since the early 2000s, AI systems have eliminated more than 1.7 million jobs, and that number will only increase as AI improves. Some research estimates that by 2025, AI will eliminate more than 85 million jobs.

But for all the talk about job security, AI is also proving to be a powerful tool in healthcare—specifically, cancer detection. One recently published study has shown that, remarkably, artificial intelligence was able to detect 20 percent more cancers in imaging scans than radiologists alone.

Keep Reading Keep Reading
Sarah Watts

Sarah Watts is a health and science writer based in Chicago.